Can pharmaceutical drugs used to treat Covid-19 infection leads to human health risk? A hypothetical study to identify potential risk

M Kumari, A Kumar - Science of the Total Environment, 2021 - Elsevier
This is the first study to assess human health risks due to the exposure of 'repurposed'
pharmaceutical drugs used to treat Covid-19 infection. The study used a six-step approach …

[HTML][HTML] Who is dying from COVID-19 and when? An Analysis of fatalities in Tamil Nadu, India

ES Asirvatham, CJ Sarman, SP Saravanamurthy… - … and Global Health, 2021 - Elsevier
Background As the number of COVID-19 cases continues to rise, public health efforts must
focus on preventing avoidable fatalities. Understanding the demographic and clinical …

Virufy: A multi-branch deep learning network for automated detection of COVID-19

A Fakhry, X Jiang, J Xiao, G Chaudhari, A Han… - arXiv preprint arXiv …, 2021 - arxiv.org
Fast and affordable solutions for COVID-19 testing are necessary to contain the spread of
the global pandemic and help relieve the burden on medical facilities. Currently, limited …

Association between laboratory parameters and CT severity in patients infected with Covid-19: A retrospective, observational study

A Yilmaz, R Sabirli, M Seyit, M Ozen, A Oskay… - The American journal of …, 2021 - Elsevier
Introduction Patients diagnosed with COVID-19 have presented to emergency departments
(EDs) worldwide with a wide range of symptoms. In this study we reported the clinical …

[HTML][HTML] COVID-19: instruments for the allocation of mechanical ventilators—a narrative review

MJ Dos Santos, MS Martins, FLP Santana… - Critical Care, 2020 - Springer
Abstract After the World Health Organization declared COVID-19 to be a pandemic, the
elaboration of comprehensive and preventive public policies became important in order to …

[HTML][HTML] SARS-CoV-2: pathogenesis, and advancements in diagnostics and treatment

K Khalaf, N Papp, JTT Chou, D Hana… - Frontiers in …, 2020 - frontiersin.org
The emergence and rapid spread of SARS-CoV-2 in December 2019 has brought the world
to a standstill. While less pathogenic than the 2002–2003 SARS-CoV, this novel …

[HTML][HTML] Subclinical myocardial dysfunction in patients with persistent dyspnea one year after COVID-19

ML Luchian, A Motoc, S Lochy, J Magne, D Belsack… - Diagnostics, 2021 - mdpi.com
Long coronavirus disease 2019 (COVID-19) was described in patients recovering from
COVID-19, with dyspnea being a frequent symptom. Data regarding the potential …

Diagnostic accuracy of non-contact infrared thermometers and thermal scanners: a systematic review and meta-analysis

N Aggarwal, M Garg, V Dwarakanathan… - Journal of Travel …, 2020 - academic.oup.com
Infrared thermal screening, via the use of handheld non-contact infrared thermometers
(NCITs) and thermal scanners, has been widely implemented all over the world. We …

[HTML][HTML] COVID-19 and the liver: What do we know after six months of the pandemic?

NA Fierro - Annals of Hepatology, 2020 - Elsevier
Despite liver injury in patients infected with severe acute respiratory syndrome (SARS)
coronavirus (CoV)-2 (SARS-CoV-2) is associated with prolonged hospitalization, and liver …

[HTML][HTML] Exit strategies: optimising feasible surveillance for detection, elimination, and ongoing prevention of COVID-19 community transmission

K Lokuge, E Banks, S Davis, L Roberts, T Street… - BMC medicine, 2021 - Springer
Background Following implementation of strong containment measures, several countries
and regions have low detectable community transmission of COVID-19. We developed an …